“In an exclusive interaction with Shweta Papriwal, Editor, IIFL Securities, Mr. Mahendra Patel, Managing Director, Lincoln Pharmaceuticals Ltd spoke about the company’s international business and growth outlook going ahead.
Lincoln Pharmaceuticals on Thursday reported a 20.44 per cent rise in its consolidated net profit to Rs 15.26 crore for the quarter ended June 30, 2020.
Mahendra G. Patel, Lincoln Pharmaceuticals. IPHEX 2017 Pharma and Health Care Exhibition Hyderabad
Shri Mahendra G Patel, CMD – Lincoln Pharma – on 140 years of BSE